News & Events

CI4CC – Fall 2017

Fall 2017 Workshop & Symposium

October 23 – 25, 2017

La Jolla, CA

GenomOncology is pleased to be a part of CI4CC’s Fall 2017 Workshop & Symposium.

June 27th, 2017|News & Events|Comments Off on CI4CC – Fall 2017

UCSF Enhances Cancer Assay with Interpretive Reporting Powered by GenomOncology’s GO Clinical Workbench

CLEVELAND, June 27, 2017 (GLOBE NEWSWIRE) — GenomOncology today announced that UC San Francisco (UCSF) is now utilizing the GO Clinical Workbench for rapid analysis and reporting of results from the “UCSF500,” an advanced next-generation sequencing panel used by researchers and physicians at the UCSF Helen Diller Family Comprehensive Cancer Center for precision cancer […]

June 27th, 2017|News & Events|Comments Off on UCSF Enhances Cancer Assay with Interpretive Reporting Powered by GenomOncology’s GO Clinical Workbench

Multi-Institution Comparison of PGM Panels Based on MolDx Technical Specifications

Clinton Miller, Director of Bioinformatics at GenomOncology, presented this poster entitled “Multi-Institution Comparison of PGM Panels Based on MolDx Technical Specifications” at AMP 2016.

Have a new NGS panel that you want to validate? We can help! Email info@genomoncology.com to find out how GenomOncology can enable your team to complete your next validation on time and […]

May 23rd, 2017|News & Events|Comments Off on Multi-Institution Comparison of PGM Panels Based on MolDx Technical Specifications

GenomOncology and med fusion announce the addition of PD-L1 Testing and Interpretation to the LungSEQ® and 50SEQ® Plus FISH Tests

CLEVELAND, March 06, 2017 (GLOBE NEWSWIRE) — med fusion, a Texas Oncology and The US Oncology Network preferred laboratory, and GenomOncology announce the expansion of med fusion’s LungSEQ® and 50SEQ® Plus FISH (for NSCLC) laboratory services to include PD-L1 expression testing. The panels will now help guide treatment selection of immunotherapeutic checkpoint inhibitors for […]

March 7th, 2017|News & Events|Comments Off on GenomOncology and med fusion announce the addition of PD-L1 Testing and Interpretation to the LungSEQ® and 50SEQ® Plus FISH Tests

GenomOncology Names Joshua F. Coleman, M.D. as New VP of Medical Affairs

CLEVELAND, Nov. 30, 2016 — GenomOncology today announced the appointment of Joshua F. Coleman, M.D., as Vice President of Medical Affairs.

Dr. Coleman will oversee clinical content development and curation of scientific evidence, enhancing the company’s proprietary knowledge-enabled platform. The GenomOncology software suite empowers molecular pathologists with a seamless workflow for the interpretation of genetic […]

November 30th, 2016|News & Events|Comments Off on GenomOncology Names Joshua F. Coleman, M.D. as New VP of Medical Affairs

Fluidigm and GenomOncology Partner To Provide Automated Oncology NGS Library Preparation With Molecular Interpretation And Reporting

Empowering clinical research laboratories to achieve new levels of productivity

SOUTH SAN FRANCISCO, Calif., Nov 8, 2016 – Fluidigm Corporation (NASDAQ:FLDM) and GenomOncology today announced a distribution agreement to co-market the GO Clinical Workbench™ for molecular interpretation of somatic variants identified using Fluidigm systems. An elegant solution for clinical research laboratories seeking accuracy, flexibility, and […]

November 9th, 2016|News & Events|Comments Off on Fluidigm and GenomOncology Partner To Provide Automated Oncology NGS Library Preparation With Molecular Interpretation And Reporting

GenomOncology Enhances the GO Clinical Workbench for Hematological Cancer Analysis and Reporting

CLEVELAND, Oct. 7, 2016 — GenomOncology today announced the recent extension of the GO Clinical Workbench™ to support Hematologic cancer testing and decision support.

Molecular diagnostic laboratories across the country have used GenomOncology’s workbench for their solid tumor testing needs for over two years. GenomOncology’s clients have recently begun to validate and launch Hematologic malignancy […]

October 7th, 2016|News & Events|Comments Off on GenomOncology Enhances the GO Clinical Workbench for Hematological Cancer Analysis and Reporting

Updates to GenomOncology’s Platform Expand Company’s Footprint in Clinical NGS Market

Sep 27, 2016 | Uduak Grace Thomas

NEW YORK (GenomeWeb) – In the two years since it launched proprietary software solutions for next-generation sequence data analysis, GenomOncology has expanded its platform to include a number of additional applications that cater to a much broader range of analysis and interpretation needs.

[…]

September 28th, 2016|News & Events|Comments Off on Updates to GenomOncology’s Platform Expand Company’s Footprint in Clinical NGS Market

Genomics England to use GenomOncology’s Knowledge Management System to Analyze Cancer Samples in the 100,000 Genomes Project

Genomics England is partnering with GenomOncology, LLC (GO) to utilize the GO Knowledge Management System (GO KMS) as a tool for clinical reporting enablement.

Genomics England will integrate the GO KMS as a key content driver to augment clinical reporting in the 100,000 Genomes Project’s cancer programme, coupling Genomics England curated database with the GO […]

September 23rd, 2016|News & Events|Comments Off on Genomics England to use GenomOncology’s Knowledge Management System to Analyze Cancer Samples in the 100,000 Genomes Project

Pathline Emerge Launches DNA Profiling Tests using GenomOncology’s GO Clinical Workbench

July 12, 2016

CLEVELAND – GenomOncology today announced that Pathline Emerge recently went live with the GO Clinical Workbench for rapid analysis and reporting of their next-generation sequencing tests.

“Pathline Emerge takes a multi-disciplinary approach to evaluate specific types of cancer to support personalized medicine. Our full-service pathology laboratory was one of the first to obtain […]

July 12th, 2016|News & Events|Comments Off on Pathline Emerge Launches DNA Profiling Tests using GenomOncology’s GO Clinical Workbench